Concepedia

Kirstine Brown‐Frandsen

KB

Statistics

Publications

7

Citations

9.6K

H-Index

7

Active since

2016

Affiliations

University of North Carolina at Chapel Hill(Current)

Novo Nordisk (Denmark)

Imperial College London

The University of Texas Southwestern Medical Center

Lunenfeld-Tanenbaum Research Institute

Kirstine Brown‐Frandsen is an author at University of North Carolina at Chapel Hill specializing in diabetes mellitus, diabetology, and medicine.

ORCID

Publications per year

2016–2023

7

Publications

7

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text

, , +13

Liraglutide and Renal Outcomes in Type 2 Diabetes

Johannes F.E. Mann, David D. Ørsted, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

, , +17

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

Steven P. Marso, Darren K. McGuire, Bernard Zinman et al. · New England Journal of Medicine · 2017 · 568 citations · Full text

, , +17

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)

Bernard Zinman, Steven P. Marso, Neil R Poulter et al. · Diabetologia · 2017 · 175 citations · Full text

, , +16

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality

Thomas R. Pieber, Steven P. Marso, Darren K. McGuire et al. · Diabetologia · 2017 · 147 citations · Full text

, , +15

1–5 of 7